BEAM — Beam Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapMomentum Trap

Annual balance sheet for Beam Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	300	966	1,078	1,190	851
Net Total Accounts Receivable
Net Total Receivables	—	300	0	—	—
Prepaid Expenses
Total Current Assets	308	1,273	1,093	1,211	878
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	125	187	234	238	216
Other Long Term Assets
Total Assets	452	1,474	1,342	1,460	1,104
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	102	213	224	206	182
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	206	648	608	478	370
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	246	827	733	981	734
Total Liabilities & Shareholders' Equity	452	1,474	1,342	1,460	1,104
Total Common Shares Outstanding